1Denhardt DT, Guo XJ. Osteopontin:a protein with diverse functions[J]. FASEB,1993,7(12) :1475.
2Tuck AB, Hota C,Wilson SM, et al. Osteopontin-induced migra- tion of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways [ J ]. Oncogene,2003,22 (8) : 1198 - 1205.
3Lin YH,Yang Yen HF. The osteopontin CD44 survival signal involves activation of the phosphatidylinositol 3-kinase/Akt signaling pathway[ J]. J Biol Chem, 2001,276(49) :46024-46030.
4Kim JH, Skates SJ, Uede T,et al. Osteopontin as a potential diagnostic biomarker for ovarian cancer [ J ]. JAMA, 2002, 287 (13) :1671-1679.
5Tiniakos DG, Yu H, Liapis H. Osteopontin expression in ovarian carcinomas and tumors of low malignant potential (LMP) [ J]. Hum Pathol, 1998,29 ( 11 ) : 1250-1254.
6Maki M, Hirota S, Kaneko Y, et al. Expression of osteopontin messenger RNA by macrophages in ovarian serous papillary cystadenocarcinoma: a possible association with calcification of psammoma bodies [ J ]. Pathol lnt, 2000,50 (7) :531-535.
7Santin AD, Zhan F, Bellone S, et al. Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epi thelium : identification of candidate molecular markers for ovarian cancer diagnosis and therapy[ J ]. Int J Cancer, 2004,112 (1) : 14-25.
8Mar G, Visintin I, Lai Y, et al. Serum protein markers for early detection of ovarian cancer[J]. Proc Natl Acad Sci USA, 2005, 102(21 ) :7677-7682.
9Brakora KA, Lee H, Yusuf R, et al. Utility of osteopontin as a biomarker in recurrent epithelial ovarian cancer[ J ]. Gynecnl Oncol, 2004,93 ( 2 ) :361-365.
10Schorge JO, Drake RD, Lee H,et al. Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer[J]. Clin Cancer Res, 2004,10 ( 10 ) : 3474 -3478.
2Webber GF.The metastasis gene osteopontin:a candidate target for cancer therapy[J].Biochimica et Biophysica Acta,2001,1552(1):61 - 85.
3Sharp JA,Sung V,Slavin J,et al.Tumor cells are the source of osteopontin and bone sialoprotein expression in human breast cancer[J].Lab Invest,1999,79(8):869-877.
4Michihiro Hirana,Fumiyuki Takahashi,Kazuhisa Takahashi,et al.Osteopontin overproduced by tumor cells acts as a potent angiogenic factor contributing to tumor growth [J].Cancer Lett,2003,198(2):107-117.
5SungV,GillesC,MurrayA,etal.The LCC15- MB human breast cancer cell line expresses osteopontin and exhibits an invasive and metastatic phenotype[J].Exp Cell Res,1998,241(4):273 - 284.
6Senger DR,Perruzzi CA.Cell migration promoted by a potent GRGDS- containing thrombin- cleavage fragment of osteopontin[J].Biochimica et Biophysica Acta,1996,1314(1):13 - 24.
7Weber GF,Ashkar S.Molecular mechanisms of tumor dissemination in primary and metastatic brain cancers[J].Brain Res Bull,2000,53(4):421-424.
8Naor D,Sionov RV,Ish- Shalom D.CD44:structure,function,and associaton with the malignant process [J].Adv Cancer Res,1997,77(4):241 - 319.
9Scott JA,Weir ML,Wilson SM,et al.Osteopontin inhibits inducible nitric oxide synthase activity in rat vascular tissue [J].Am J Physiol,1998,275(11):H2258 - H2265.
4Luo Z, Zhang Q, Zhao Z, et al. OLFM4 is associated with lymph node metastasis and poor prognosis in pa- tients with gastric cancer. J Cancer Res Clin Oncol, 2011, 137: 1713-1720.
5Cho H, Kang ES, Kim YT, et al. Diagnostic and prog- nostic impact of osteopontin expression in endometrial cancer. Cancer Invest, 2009, 27: 313-323.
6Briese J, Schulte HM, Bamberger CM, et al. Expres- sion pattern of osteopontin in endometrial carcinoma: correlation with expression of the adhesion molecule CEACAM1. Int J Gynecol Pathol, 2006, 25 : 161-169.
7Pozharisskii KM, Samsonova EA, Ten VP, et al. Im- munohistochemical profile of endometrioid adenocarcino- ma of the uterus: ER, PR, HER-2, Ki-67 and their prognostic value. Arkh Patol, 2005, 67: 13-17.
8ShevdeLA, DasS,ClarkDW,etal. Osteopontin: aneffectorand aneffect of tumor metastasis [ J]. Current Molecular Medicine,2010,12(26)=159-163.
